Targeting Acod1/itaconate in cancer therapy: Mechanisms and opportunities
Globally, cancer claims nearly 10 million lives annually, where tumor heterogeneity, the immunosuppressive microenvironment, and therapeutic resistance constitute fundamental clinical challenges. In recent years, immunometabolic reprogramming has emerged as a cutting-edge research frontier, revealin...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2026-03-01
|
| coleção: | Pharmacological Research |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S104366182600054X |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|